Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

CRUK Brain Tumour Conference

1 - 3 May 2018

The Royal Society of Medicine, London, United Kingdom of Great Britain and Northern Ireland

Issues with treating brain cancers through the blood-brain barrier

Dr Tim Phoenix - Cincinnati Children’s Hospital Medical Center, Cincinnati, USA

Issues with treating brain cancers through the blood-brain barrier ( Dr Tim Phoenix - Cincinnati Children’s Hospital Medical Center, Cincinnati, USA )

Tumour evolution in brain cancer

Dr Roel Verhaak - The Jackson Laboratory, Farmington, USA

Tumour evolution in brain cancer ( Dr Roel Verhaak - The Jackson Laboratory, Farmington, USA )

Molecular classification in brain tumours

Dr Mark Gilbert - National Cancer Institute, Bethesda, USA

Molecular classification in brain tumours ( Dr Mark Gilbert - National Cancer Institute, Bethesda, USA )

PDX imaging models in brain tumours

Prof Kevin Brindle - Cancer Research UK Cambridge Institute, Cambridge, UK

PDX imaging models in brain tumours ( Prof Kevin Brindle - Cancer Research UK Cambridge Institute, Cambridge, UK )

The tumour microenvironment in primary brain cancers

Dr Johanna Joyce - Ludwig Institute for Cancer Research and the University of Lausanne, Lausanne, Switzerland

The tumour microenvironment in primary brain cancers ( Dr Johanna Joyce - Ludwig Institute for Cancer Research and the University of Lausanne, Lausanne, Switzerland )

New funding in brain tumour research

David Jenkinson - Chief Scientific Officer, The Brain Tumour Charity, UK

New funding in brain tumour research ( David Jenkinson - Chief Scientific Officer, The Brain Tumour Charity, UK )

Blocking molecules responsible for rapid glial growth

Dr Michelle Monje - Stanford University, Stanford, USA

Blocking molecules responsible for rapid glial growth ( Dr Michelle Monje - Stanford University, Stanford, USA )

Understanding the tumour microenvironment to maximise treatment response

Dr Gabrielle Bergers - University of Leuven, Leuven, Belgium

Understanding the tumour microenvironment to maximise treatment response ( Dr Gabrielle Bergers - University of Leuven, Leuven, Belgium )

Overcoming the blood-brain barrier to treat glioblastoma

Prof Elga De Vries - VU University Medical Center, Amsterdam, The Netherlands

Overcoming the blood-brain barrier to treat glioblastoma ( Prof Elga De Vries - VU University Medical Center, Amsterdam, The Netherlands )

Movement and growth of cells throughout the leptomeningeal space

Dr Adrienne Boire - Memorial Sloan Kettering Cancer Centre , New York, USA

Movement and growth of cells throughout the leptomeningeal space ( Dr Adrienne Boire - Memorial Sloan Kettering Cancer Centre , New York, USA )

Modelling medulloblastoma in mice using stem cells

Dr William Weiss - University of California San Diego, San Diego, USA

Modelling medulloblastoma in mice using stem cells ( Dr William Weiss - University of California San Diego, San Diego, USA )

Pre-clinical models in brain cancer

Dr Mark Gilbert - National Cancer Institute, Bethesda, USA

Pre-clinical models in brain cancer ( Dr Mark Gilbert - National Cancer Institute, Bethesda, USA )

Passage of treatments at the blood-brain barrier

Prof William Elmquist - University of Minnesota, Minneapolis, USA

Passage of treatments at the blood-brain barrier ( Prof William Elmquist - University of Minnesota, Minneapolis, USA )

Diagnostics and classification of brain tumours

Dr David Louis - Massachusetts General Hospital, Boston, USA

Diagnostics and classification of brain tumours ( Dr David Louis - Massachusetts General Hospital, Boston, USA )

Personalised approaches to paediatric ependymoma

Dr Stephen Mack - Baylor College of Medicine, Houston, USA

Personalised approaches to paediatric ependymoma ( Dr Stephen Mack - Baylor College of Medicine, Houston, USA )

Identifying drivers of resistance in childhood brain tumours

Dr Pratiti Bandopadhayay - Dana-Farber Cancer Institute, Boston, USA

Identifying drivers of resistance in childhood brain tumours ( Dr Pratiti Bandopadhayay - Dana-Farber Cancer Institute, Boston, USA )

Single cell genomic technologies in brain tumours

Dr Mario Suvà - Massachusetts General Hospital, Boston, USA

Single cell genomic technologies in brain tumours ( Dr Mario Suvà - Massachusetts General Hospital, Boston, USA )

Cancer Research UK Brain Tumour Conference

Dr Johanna Joyce - Ludwig Institute for Cancer Research and the University of Lausanne, Lausanne, Switzerland

Cancer Research UK Brain Tumour Conference ( Dr Johanna Joyce - Ludwig Institute for Cancer Research and the University of Lausanne, Lausanne, Switzerland )

Lessons from mouse models of glioblastoma

Dr Luis Parada - Memorial Sloan Kettering Cancer Center, New York, USA

Lessons from mouse models of glioblastoma ( Dr Luis Parada - Memorial Sloan Kettering Cancer Center, New York, USA )

Funding collaborations and discovery in treating brain cancers

Dr Iain Foulkes - Executive Director, Research & Innovation / CEO of Cancer Research Technology

Funding collaborations and discovery in treating brain cancers ( Dr Iain Foulkes - Executive Director, Research & Innovation / CEO of Cancer Research Technology )

Incorporating biomarkers into clinical trial design

Dr Amar Gajjar - St. Jude Children's Research Hospital, Memphis, USA

Incorporating biomarkers into clinical trial design ( Dr Amar Gajjar - St. Jude Children's Research Hospital, Memphis, USA )

More from ecancer